Alan Fersht 个人学术档案 - 学术资源搜索

引用次数

	总计	2019 年至今
引用	95390	12278
h 指数	162	53
i10 指数	568	255

3700

1850

925

2775

1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024424 541 730 681 737 847 1032 1125 1423 1611 1985 2110 2430 2562 2688 2727 2909 3010 2707 3115 3246 3335 3395 3654 3439 3265 3371 3512 3328 3056 2664 2922 2597 2742 2495 2353 2366 2256 1959 848

开放获取的出版物数量

查看全部

36 篇文章

3 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

合著作者

Andreas C. JoergerStructural Genomics Consortium (SGC), Institute of Pharmaceutical Chemistry, Goethe University在 pharmchem.uni-frankfurt.de 的电子邮件经过验证
Valerie D. DaggettProfessor of Bioengineering, University of Washington在 uw.edu 的电子邮件经过验证
Christopher M JohnsonMRC Laboratory of Molecular Biology在 mrc-lmb.cam.ac.uk 的电子邮件经过验证
Dmitry VeprintsevProfessor of Molecular and Cellular Pharmacology, University of Nottingham在 nottingham.ac.uk 的电子邮件经过验证
Andreas MatouschekThe University of Texas at Austin在 austin.utexas.edu 的电子邮件经过验证
Ashley BuckleReplay在 replay.bio 的电子邮件经过验证
Gideon schreiberweizmann or hadassah or cambridge在 weizmann.ac.il 的电子邮件经过验证
Prof. Assaf FriedlerInstitute of Chemistry, The Hebrew University of Jerusalem在 mail.huji.ac.il 的电子邮件经过验证
Javier sanchoprofessor of biochemistry, universidad de zaragoza在 unizar.es 的电子邮件经过验证
Paul J. CarterGenentech在 gene.com 的电子邮件经过验证
Dr S.E. JacksonUniversity of Cambridge在 cam.ac.uk 的电子邮件经过验证
Ugo MayorUniversity of the Basque Country UPV/EHU & Ikerbasque在 ehu.eus 的电子邮件经过验证
Frank M. BoecklerUniv. Professor, Lab for Molecular Design & Pharm. Biophysics, Eberhard Karls University Tuebingen在 uni-tuebingen.de 的电子邮件经过验证
Tim SharpeUniversity of Basel在 unibas.ch 的电子邮件经过验证
Robin LeatherbarrowImperial College London在 imperial.ac.uk 的电子邮件经过验证
Matthias R. BauerNovartis Institutes for BioMedical Research在 novartis.com 的电子邮件经过验证
Gonzalo de Prat GayHead, Protein Structure-Function and Engineering Lab, Fundación Instituto Leloir-CONICET, Argentina在 leloir.org.ar 的电子邮件经过验证
Kam-Bo WONGProfessor, School of Life Sciences, The Chinese University of Hong Kong在 cuhk.edu.hk 的电子邮件经过验证
Mary Miu Yee WayeThe Chinese University of Hong Kong在 cuhk.edu.hk 的电子邮件经过验证
Stefano Gianni在 uniroma1.it 的电子邮件经过验证

关注

Alan Fersht

Emeritus Group Leader, MRC Laboratory of Molecular Biology, University of Cambridge

在 cam.ac.uk 的电子邮件经过验证 - 首页

protein folding misfolding p53 and cancer


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Enzyme Structure and Mechanism A Fersht WH Freeman, New York, NY, 1977	6436	1977
Structure and mechanism in protein science: a guide to enzyme catalysis and protein folding A Fersht Macmillan, 1999	5689	1999
Hydrogen bonding and biological specificity analysed by protein engineering AR Fersht, JP Shi, J Knill-Jones, DM Lowe, AJ Wilkinson, DM Blow, ... Nature 314 (6008), 235-238, 1985	1342	1985
Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition SE Jackson, AR Fersht Biochemistry 30 (43), 10428-10435, 1991	1148	1991
Awakening guardian angels: drugging the p53 pathway CJ Brown, S Lain, CS Verma, AR Fersht, DP Lane Nature Reviews Cancer 9 (12), 862-873, 2009	1099	2009
The folding of an enzyme: I. Theory of protein engineering analysis of stability and pathway of protein folding AR Fersht, A Matouschek, L Serrano Journal of molecular biology 224 (3), 771-782, 1992	1066	1992
The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for … LS Itzhaki, DE Otzen, AR Fersht Journal of molecular biology 254 (2), 260-288, 1995	969	1995
Mapping the transition state and pathway of protein folding by protein engineering A Matouschek, JT Kellis Jr, L Serrano, AR Fersht Nature 340 (6229), 122-126, 1989	894	1989
Rescuing the function of mutant p53 AN Bullock, AR Fersht Nature Reviews Cancer 1 (1), 68-76, 2001	825	2001
Structural Biology of the Tumor Suppressor p53 A Joerger, AR Fersht Annual Review of Biochemistry 77, 557-582, 2008	793	2008
Nucleation mechanisms in protein folding AR Fersht Current opinion in structural biology 7 (1), 3-9, 1997	767	1997
Energetics of protein-protein interactions: Analysis ofthe Barnase-Barstar interface by single mutations and double mutant cycles G Schreiber, AR Fersht Journal of molecular biology 248 (2), 478-486, 1995	727	1995
The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus) PJ Carter, G Winter, AJ Wilkinson, AR Fersht Cell 38 (3), 835-840, 1984	712	1984
Rapid, electrostatically assisted association of proteins G Schreiber, AR Fersht Nature structural biology 3 (5), 427-431, 1996	702	1996
Optimization of rates of protein folding: the nucleation-condensation mechanism and its implications. AR Fersht Proceedings of the National Academy of Sciences 92 (24), 10869-10873, 1995	670	1995
The hydrogen bond in molecular recognition AR Fersht Trends in Biochemical Sciences 12, 301-304, 1987	656	1987
PRIMA-1 reactivates mutant p53 by covalent binding to the core domain JMR Lambert, P Gorzov, DB Veprintsev, M Söderqvist, D Segerbäck, ... Cancer cell 15 (5), 376-388, 2009	651	2009
The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches AC Joerger, AR Fersht Annual review of biochemistry 85, 375-404, 2016	642	2016
Protein folding and unfolding at atomic resolution AR Fersht, V Daggett Cell 108 (4), 573-582, 2002	627	2002
Is there a unifying mechanism for protein folding? V Daggett, AR Fersht Trends in biochemical sciences 28 (1), 18-25, 2003	611	2003

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用